Latin America Human Insulin Drugs Market Share

Market Share of Latin America Human Insulin Drugs Industry

The Latin American Human Insulin Market is highly fragmented, with three major manufacturers having a large market share. In the United States, there are no other players except Novo Nordisk, Sanofi, and Eli Lilly. While in the remaining countries, the manufacturers confine to the other local or region-specific manufacturers. Mergers and acquisitions between the players in the recent past helped the companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance in developing and commercializing Basaglar (insulin glargine).

Latin America Human Insulin Drugs Market Leaders

1. Novo Nordisk

2. Eli Lilly

3. Sanofi

4. Biocon

5. Pfizer

*Disclaimer: Major Players sorted in no particular order